However, in patients with type I diabetes, the plasma irisin level is significantly lower than that in healthy people (Tentolouris et al., 2018), thus irisin is expected to be a new treatment for diabetes (Leung, 2017). The gene discussed is FNDC5; the disease is type 1 diabetes mellitus.